Green Cross Holdings Corporation (KRX:005250)

Market Cap	696.92B -5.7%
Revenue (ttm)	2.40T +9.9%
Net Income	127.58B
EPS	2,832.40
Shares Out	45.40M
PE Ratio	5.42
Forward PE	n/a
Dividend	500.00 (3.31%)
Ex-Dividend Date	n/a

Volume	33,955
Average Volume	111,827
Open	14,990
Previous Close	14,850
Day's Range	14,890 - 15,130
52-Week Range	12,000 - 17,700
Beta	0.55
RSI	48.73
Earnings Date	Feb 10, 2026

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1967
• Employees: 144
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 005250